XOLAIR

UNIISPLATC R03DX05

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerGenentech, Inc.

CountryUS (United States)

ATC codeR03DX05

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 2

ndc11
5024204062
1 VIAL, SINGLE-USE in 1 CARTON (50242-040-62) / 1.2 mL in 1 VIAL, SINGLE-USE
ndc11
5024204086
1 VIAL, SINGLE-USE in 1 CARTON (50242-040-86) / 1.2 mL in 1 VIAL, SINGLE-USE

Annotations

UNII (FDA Substance ID)

2P471X1Z11

OMALIZUMAB

RxCUI 302379

DailyMed SPL labels

1 version tracked

Raw payload (JSON)

{
  "unii": {
    "unii": "2P471X1Z11",
    "rxcui": "302379",
    "inchikey": null,
    "display_name": "OMALIZUMAB",
    "substance_type": "protein",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "SUBCUTANEOUS",
  "spl_meta": {
    "7f6a2191-adfb-48b9-9bfa-0d9920479f0d": {
      "match": "brand_token",
      "title": "XOLAIR (OMALIZUMAB) INJECTION, SOLUTION XOLAIR PFS (OMALIZUMAB) INJECTION, SOLUTION XOLAIR (OMALIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.]",
      "spl_version": "31",
      "published_date": "2025-12-10"
    }
  },
  "productid": "50242-040_e633fdb6-7fbc-4072-93ed-4e30abc6c3a1",
  "productndc": "50242-040",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "OMALIZUMAB",
  "proprietary_name": "XOLAIR",
  "active_ingred_unit": "mg/1.2mL",
  "application_number": "BLA103976",
  "marketing_category": "BLA",
  "nonproprietary_name": "omalizumab",
  "start_marketing_date": "20030620",
  "active_numerator_strength": "150"
}

Related drugs

Other records sharing ATC code R03DX05.

Access this data programmatically

Query XOLAIR and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs